Fig. 2From: Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patientsLogit function from the multivariable logistic regression model in the group of all patients (right) showing the effect of delay in administration of IgM-enriched immunoglobulins on the probability of in-ICU death (solid line) with 95% confidence interval (gray area) adjusted to median value of SAPS II, SOFA D1 and without fungal infection. Comparison with logit functions from the multivariable logistic regression model for MDR-positive patients adjusted for median value of SAPS II (left). ivIgGAM, intravenous IgM- and IgA-enriched immunoglobulins; ICU, intensive care unit; MDR, multidrug resistant; SAPS II, Simplified Acute Physiology Score; SOFA D1, sequential organ failure assessment calculated the first day of administration of ivIgGAMBack to article page